Chancellor Rachel Reeves Plans Targeted Measures on Household Expenses in Forthcoming Financial Plan
Treasury head Reeves has announced she is preparing "specific action to deal with cost of living issues" in next month's Budget.
During an interview with the BBC, she emphasized that lowering price rises is a shared responsibility of both the government and the Bank of England.
The UK's price growth is projected to be the most elevated among the G7 developed nations this calendar year and the following year.
Potential Energy Bill Interventions
It is understood the administration could take action to lower utility costs, such as by cutting the present 5% rate of value-added tax charged on energy supplies.
An additional option is to reduce some of the government charges presently added to bills.
Budgetary Constraints and Expert Expectations
The government will obtain the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much space there is for such measures.
The consensus from the majority of analysts is that the Chancellor will have to introduce tax rises or budget cuts in order to meet her declared debt limits.
Earlier on Thursday, estimates suggested there was a twenty-two billion pound shortfall for the Treasury chief to resolve, which is at the lower end of projections.
"There's a shared task between the Bank of England and the administration to continue tackling some of the drivers of inflation," the Chancellor informed reporters in the US capital, at the conferences of the International Monetary Fund and global financial institution.
Revenue Commitments and International Issues
While a great deal of the focus has been on likely tax increases, the chancellor said the most recent figures from the fiscal watchdog had not changed her pledge to campaign commitments not to raise rates on income tax, sales tax or National Insurance.
She blamed an "unpredictable world" with increasing international and commercial tensions for the Budget tax moves, probably to be targeted on those "with the broadest shoulders."
Global Economic Tensions
Addressing apprehensions about the United Kingdom's commercial links with the Asian nation she said: "Our security interests invariably take priority."
Last week's statement by China to tighten trade restrictions on critical minerals and other materials that are crucial for high-technology production led American leader the US President to suggest an extra 100% import tax on goods from the Asian country, raising the risk of an full-scale commercial conflict between the two largest economies.
The US Treasury Secretary described the Chinese action "economic coercion" and "a international production control attempt."
Asked about considering the American proposal to join its conflict with China, the Chancellor said she was "very concerned" by Chinese measures and urged the Beijing authorities "not to put up barriers and restrict access."
She said the action was "bad for the international commerce and creates further obstacles."
"In my view there are areas where we must address China, but there are also important opportunities to export to China's economy, including banking sector and other areas of the economic system. We've got to achieve that equilibrium appropriate."
The chancellor also confirmed she was working with international partners "regarding our own critical minerals plan, so that we are reduced dependence."
NHS Medicine Pricing and Funding
Reeves also recognized that the price the National Health Service pays for medicines could increase as a consequence of ongoing discussions with the Trump administration and its drugs companies, in return for reduced taxes and capital.
A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or scrapping investments in the United Kingdom, with several blaming the low prices they are receiving.
Recently, the government science advisor said the price the health service spends on drugs would have to rise to stop firms and pharmaceutical investment leaving the UK.
The Chancellor informed the BBC: "It has been observed as a result of the pricing regime, that drug testing, recent pharmaceuticals have not been offered in the United Kingdom in the manner that they are in other European countries."
"The objective is to make sure that individuals getting treatment from the National Health Service are can access the finest essential treatments in the globe. And so we are examining these issues, and... seeking to secure increased capital into the UK."